Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

BOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA0375

FDA Recall Z-2481-2021 · Posted None

Recalling FirmLeica Microsystems, Inc.
Recall StatusTerminated
Product CodeNJT
Date Initiated2021-07-30
Date Terminated2023-06-22
Product Quantity237 units

Reason for Recall

Product may not perform as specified in IFU.

Firm Action

The firm notified their consignees by email on 07/30/2021. The notice explained the issue and requested destruction of the product.

Root Cause

Unknown/Undetermined by firm

Distribution Pattern

US Nationwide distribution.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑